<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Healthcare on AI Brief | AI-101.tech</title><link>https://AI-101.tech/tags/healthcare/</link><description>Recent content in Healthcare on AI Brief | AI-101.tech</description><generator>Hugo</generator><language>en</language><lastBuildDate>Sun, 29 Mar 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://AI-101.tech/tags/healthcare/index.xml" rel="self" type="application/rss+xml"/><item><title>A Giant Leap for Medicine: AI Reduces Drug Development Cycle from Years to Months</title><link>https://AI-101.tech/posts/2026-03-29-ai-drug-discovery-breakthrough/</link><pubDate>Sun, 29 Mar 2026 00:00:00 +0000</pubDate><guid>https://AI-101.tech/posts/2026-03-29-ai-drug-discovery-breakthrough/</guid><description>&lt;p>In the biopharmaceutical industry, a cruel &amp;ldquo;10-10 law&amp;rdquo; has persisted: developing a new drug takes an average of 10 years and costs $1 billion. However, this pattern is being thoroughly shattered by artificial intelligence (AI). Recently, a biotech company announced that using its AI-driven platform, it completed the entire process from &amp;ldquo;discovering drug targets&amp;rdquo; to &amp;ldquo;identifying clinical candidate drugs&amp;rdquo; in just &lt;strong>6 months&lt;/strong>, setting a new industry record.&lt;/p>
&lt;h2 id="digital-simulation-replaces-laboratory-trial-and-error">Digital Simulation Replaces Laboratory Trial and Error&lt;/h2>
&lt;p>Traditional drug development is like finding a needle in a dark ocean—scientists must manually synthesize and test tens of thousands of compounds to find one promising molecule. The core of this breakthrough lies in the AI platform&amp;rsquo;s &lt;strong>high-dimensional simulation capabilities&lt;/strong>.&lt;/p></description></item></channel></rss>